New lung cancer therapies and the importance of patients being proactive

Janet Freeman-Daily

Lung Cancer Patient/Activist Janet Freeman-Daily talks about how the development of new therapies means there are disparities between doctors and nations between access and knowledge to these therapies. Ms Freeman-Daily stresses patients must use advocacy groups, and initiatives to get patients tested and find clinical trials. She points to the fact that she discovered her treatment through an online patient group. Recorded at the 2016 World Conference of Lung Cancer (WCLC) of the International Association for the Study of Lung Cancer (IASLC) in Vienna, Austria.

Share this video  
Similar topics
Related videos
0:49
Managing long term effects of childhood cancer
Martin Schrappe
3:33
Nurse-led rapid access lung cancer clinic in Wales: a case study
Sarah Morgan
2:21
Update on European initiatives to influence policy and make cancer care more efficient
Matti Aapro
5:16
Biosimilars: what oncologists need to know
Fernando de Mora Perez
1:09
Teamwork between urologists and oncologists in the UK
Mark Emberton
Lung Cancer
WCLC 2016
Interview
4th December 2016
More from Janet Freeman-Daily
The successes of novel therapies and molecular testing in lung cancer and patient access
VJOncology is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

VJO needs the contact information you provide to inform you about our latest oncology news and videos, educational courses and industry supported content (some of which may be promotional in nature). You may unsubscribe from these communications at anytime. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy.

The content of VJOncology is intended for healthcare professionals